The measles vaccine could make COVID-19 cases less severe — and therefore more survivable, propose microbiologists.
A provider-sponsored survey recently uncovered huge backlogs of therapy claim reviews for beneficiaries who exceeded the Medicare Part B caps limits.
Please login or register first to view this content.
Login Register